CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2019—BD announced the EU launch of its CE-IVD-marked BD COR, an automated, high-throughput molecular diagnostics system developed for large-capacity laboratories. The system allows samples to be processed directly from liquid-based cytology vials and is capable of running the diagnostic workflow from preanalytical processing to test result. It has on-board capacity for reagents and samples to provide up to 360 results in eight hours. The modular and scalable system will be available with the BD Onclarity HPV Assay for the detection and extended genotyping of human papillomavirus. The company plans to continue seeking regulatory authorizations to sell the BD COR System worldwide and expand the menu to include assays for infectious diseases.